Researchers are exploring new treatment options for chronic myeloid leukemia (CML). Many treatments that have recently been studied or are currently under investigation are targeted therapy drugs.

This approach to the treatment of colonic involvement of CMML has not been previously described in the literature. In this patient, the initially stable WBC count contributed to a delay in ...

Her medical history was notable for chronic myelomonocytic leukemia, diagnosed 6 years previously and managed expectantly by monitoring the patient's complete blood count. Over several months ...

Tasigna is used in adults and certain children to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). An interaction can occur because one substance causes another ...

Itacitinib adipate is under clinical development by Incyte and currently in Phase II for Chronic Myelomonocytic Leukemia (CMML). According to GlobalData, Phase II drugs for Chronic Myelomonocytic ...

Canakinumab is under clinical development by Novartis and currently in Phase II for Chronic Myelomonocytic Leukemia (CMML). According to GlobalData, Phase II drugs for Chronic Myelomonocytic Leukemia ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Chronic myeloid (or myelogenous) leukaemia (CML), also known as chronic granulocytic leukaemia, is a cancer of the white blood cells. It is characterized by the increased and unregulated growth of ...

The genetics behind the progression of myelodysplasia to secondary acute myeloid leukemia (sAML) is poorly understood. In this study, we profiled somatic mutations and their dynamics using next ...

In MPNs, too many blood stem cells (immature cells) in the bone marrow develop into mature blood cells. These extra cells build up in the blood and bone marrow over time. This condition usually gets ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...